Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli

Vaccine

Volumn 18, Issue 17, 2000, Pages 1811-1821

  De, B K ^a   Sampson, J S ^b   Ades, E W ^b   Huebner, R C ^a   Jue, D L ^a   Johnson, S E ^a   Espina, M ^a   Stinson, A R ^a   Briles, D E ^c   Carlone, G M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Pasteur Merieux Connaught   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Bacterial lipoproteins; Recombinant PsaA; S. pneumoniae

Indexed keywords

ADHESIN; PNEUMOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; IMMUNOGENICITY; MOUSE; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADHESINS, BACTERIAL; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; CHOLERA TOXIN; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ESCHERICHIA COLI; FEMALE; IMMUNOGLOBULIN G; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED CBA; MOLECULAR WEIGHT; PALMITIC ACIDS; PROTEIN SORTING SIGNALS; SALIVA; STREPTOCOCCUS PNEUMONIAE; VACCINES, SYNTHETIC;

EID: 17744407501     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00481-8     Document Type: Article

References (40)

1. Prevention of pneumococcal diseases: Recommendations of the Advisory Committee on Immunization Practices. 1999. MMWR, 46 (RR8).
2. Lee C.J., Wang T.R. Pneumococcal infection and immunization in children. Crit. Rev. Microbl. 20:1994;1-12.
3. Kayhty H., Eskola J. New vaccines for the prevention of pneumococcal infections. Emerg. Infect. Dis. 2:1995;289-298.
4. Eby R. Pneumococcal conjugate vaccines. Pharm. Biotec. 6:1995;695-718.
5. Pallares R., Viladrich P.F., Linares J., Cabellos C., Gudiol F. Impact of antibiotic resistance on chemotherapy for pneumococcal infections. Microb. Drug Resist.-Mech. Epi. Dis. 4:1998;339-347.
6. Mufson M.A. Penicillin-resistant Streptococcus pneumoniae increasingly threatens the patient and challenges the physician. Clin. Infect. Dis. 27:1998;771-773.
7. Butler J.C., Dowell S.F., Breiman R.F. Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine. 16:1998;1693-1697.
8. McCormick J.B. Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens. Curr. Opin. Microbiol. 1:1998;125-129.
9. Kuo J., Douglas M., Ree K.H., Lindberg A.A. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines. Infect. Immun. 63:1995;2706-2713.
10. Tart R.C., McDaniel L.S., Ralph B.A., Briles D.E. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 173:1996;380-386.
11. Briles D.E., King J.D., Gray M.A., McDaniel L.S., Swiatlo E., Benton K.A. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine. 14:1996;858-867.
12. Brooks-Walter A., Tart R.C., Briles D.E., Hollingshead S.K. The pspC gene encodes a second pneumococcal surface protein homologous to the gene encoding the protection-eliciting PspA protein of Streptococcus pneumoniae. ASM Annual Meeting. 1997;35.
13. Russell H., Tharpe J.A., Wells D.E., White E.H., Johnson J.E. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J. Clin. Microb. 28:1990;2191-2195.
14. Sampson J.S., O'Connor S.P., Stinson A.P., Tharpe J.A., Russell H. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. Adhesins. Infect. Immun. 62:1994;319-324.
15. Talkington D.F., Brown B.G., Tharpe J.A., Koenig A., Russell H. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb. Pathog. 21:1996;17-22.
16. De B.K., Sampson J.S., Ades E.W., Johnson S.E., Stinson A.R., Crook J., Tharpe J.A., Huebner R.C., Carlone G.M. Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae. Pathobiology. 67:1999;115-122.
17. McDaniel L.S., McDaniel D.O., Hollingshead S.K., Briles D.E. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types. Infect. Immun. 66:1998;4748-4754.
18. Briles DE, Ades EW, Paton JC. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage (personal communication).
19. Crook J., Tharpe J.A., Johnson S.E., Williams D.B., Stinson A.R., Facklam R.R., Ades E.W., Carlone G.M., Sampson J.S. Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin. Diag. Lab. Immunol. 5:1998;205-210.
20. Tharpe J.A., Russell H., Leinonen M., Plikaytis B.D., Breiman R.F., Carlone G.M., Ades E.W., Sampson J.S. Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody. Pathobiology. 66:1998;77-83.
21. Tharpe J.A., Russell H. Purification and seroreactivity of pneumococcal surface adhesin A (PsaA). Clin. Diag. Lab. Immunol. 3:1996;227-229.
22. Wu H.C., Tokunaga M. Biogenesis of lipoproteins in bacteria. Curr. Top. Microbiol. Immunol. 125:1986;127-157.
23. Erdile L.F., Brandt M., Warakomski D.J., Westrack G.J., Sadziene A., Babour A.G., Mays J.P. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:1993;81-90.
24. Gonzalezchristen J., Vergne I., Sussmuth R., Sidobre S., Prats M., Tocanne J.F., Laneelle G. Adjuvant lipopeptide interaction with model membranes. Biochim. Biophysi. Acta-Biomembranes. 1368:1998;97-107.
25. Sutcliffe I.C., Russell R.R.B. Lipoproteins of gram-positive bacteria. J. Bacteriol. 177:1995;1123-1128.
26. Pilling P.A., Lawrence M.C., Berry A.M., Ogunniyi A.D., Lock R.A., Paton J.C. Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal transporter protein of Streptococcus pneumoniae. Acta Cryst. D54:1998;1464-1466.
27. Lawrence M.C., Pilling P.A., Epa V.C., Berry A.M., Ogunniyi A.D., Paton J.C. The crystal structure of pneumococcal surface antigen PsaA reveals a metal binding site and a novel structure for a putative ABC-type binding protein. Structure. 6:1998;1553-1561.
28. Sampson J.S., Furlow Z., Whitney A.M., Williams D., Facklam R., Carlone G.M. Limited diversity of Streptococcus pneumoniae PsaA among pneumococcal vaccine serotypes. Infect. Immun. 65:1997;1967-1971.
29. Bouchon B., Klein M., Bischoff R., Dorsselaer A.V., Roitsch C. Analysis of the lipidated recombinant outer surface protein A from Borrelia burgdorferi by mass spectrometry. Anal. Biochem. 246:1997;53-61.
30. Lewis J.K., Bendahmane M., Smith T.J., Beachy R.N., Siuzdak G. Identification of viral mutants by mass spectrometry. Proc. Natl. Acad. Sci. USA. 95:1998;8596-8601.
31. Braun V., Wu H.C. Lipoproteins, structure, function, biosynthesis and model for protein export. Ghuysen J.-M., Hakenbeck R. Bacterial Cell Wall. 1994;319-341 Elsevier Science, B.V.
32. Sankaran K., Gupta S.D., Wu H.C. Modification of bacterial lipoproteins. Casey P.J., Buss J.E. Methods in enzymology. 1995;683-697 Academic Press.
33. Jenkinson H.F., Lamont R.J. Streptococcal adhesion and colonization [Review]. Crit. Rev. Oral Biol. Med. 8:1997;175-200.
34. Wu H.C. Biosynthesis of lipoproteins. Escherichia coli and Salmonella: Cellular and Molecular Biology. 2nd ed. 1996;1005-1014 American Society of Microbiology Press, Washington, DC.
35. Steere A.C., Sikland V.K., Meurice F., Parenti D.L., Fikrig E., Schoen R.T., Nowakowski J., Schmid C.H., Laukamp S., Buscarino C., Krause D.S., Lyme Disease Vaccine Study Group. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface lipoprotein A with adjuvant. N. Engl. J. Med. 339:1998;209-215.
36. Sigal L.H., Zahradnik J.M., Lavin P., Patella S., Bryant G., Haselby R., Hilton E., Kunkel M., Adler-Klein D., Doherty T., Evans J., Malawista S.E., The Recombinant Outer.-surface Protein A. Lyme Disease Vaccine Study Consortium. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease. N. Engl. J. Med. 339:1998;216-222.
37. pET system manual. 6th ed. 1995;Novagen, Inc, Madison, Wisconsin.
38. Wallich R., Simon M.M., Hofmann H., Moter S.E., Schaible U.E., Kramer M.D. Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi. Infect. Immun. 61:1993;4158-4166.
39. Honavar N., Schaible U.E., Galanos C., Wallich R., Simon M.M. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology. 82:1994;389-396.
40. Radolf J.D., Arndt L.L., Akins D.R., Curretty L.L., Levi M.E., Shen Y., Davis L.S., Norgard M.V. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:1995;2866-2877.